Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Drug Targets|March 22, 2005
Peptide YY: a potential therapy for obesityD Renshaw, R L Batterham
Journal of Endocrinological Investigation|May 7, 2018
Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet differentA Pucci, R L Batterham
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 2, 2018
Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysisF-F Wang, Y Wu, Y-H Zhu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2016
Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetesS Steven, K G Hollingsworth, P K Small, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Pancreatic polypeptide reduces appetite and food intake in humansR L Batterham, C W Le Roux, M A Cohen, et al.
Diabetes|October 27, 2001
Ghrelin causes hyperphagia and obesity in ratsA M Wren, C J Small, C R Abbott, et al.
Endocrinology|September 17, 2005
Attenuated peptide YY release in obese subjects is associated with reduced satietyC W le Roux, R L Batterham, S J B Aylwin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 22, 2017
Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scoresA Pucci, U Tymoszuk, W H Cheung, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 5, 2012
Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in miceC Gelegen, K Chandarana, A I Choudhury, et al.
Pageof 2